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Accumulation of amyloid-b (Ab) is a hallmark of Alzheimer’s disease, a neurodegenerative disorder in
which synapse loss and dysfunction are early features. Acute exposure of hippocampal slices to Ab leads to
changes in synaptic plasticity, specifically reduced long-term potentiation (LTP) and enhanced long-term
depression (LTD), with no change in basal synaptic transmission. We also report here that D-AP5, a
non-selective NMDA receptor antagonist, completely prevented Ab-mediated inhibition of LTP in area
CA1 of the hippocampus. Ro25-6981, an antagonist selective for GluN2B (NR2B) NMDA receptors, only
partially prevented this Ab action, suggesting that GluN2A and GluN2B receptors may both contribute to
Ab suppression of LTP. The effect of Ab on LTP was also examined in hippocampal slices from BAX 2/2
mice and wild-type littermates. Ab failed to block LTP in hippocampal slices from BAX 2/2 mice,
indicating that BAX is essential for Ab inhibition of LTP.
D
espite much evidence for a central role of amyloid-beta (Ab) in the pathogenesis of Alzheimer’s disease,
the mechanism(s) by which Ab produces structural and functional synaptic deficits remain unclear.
NMDA receptors are thought to be essential for a number of Ab-induced defects in synaptic structure,
including degradation of key synaptic proteins, disassembly of the postsynaptic density, and synapse loss
1–4.
However, the role of NMDA receptors in Ab-induced changes in functional synaptic plasticity is less clear.
NMDA receptors are heterotetramers made up of two GluN1 (also known as NR1) subunits and two GluN2
(NR2) subunits. GluN2A andGluN2B are the primary NR2subunits in thehippocampus. A number of recentin
vitro studies
5–7haveexamined the roleof GluN2Breceptors inAbimpairment ofLTP andreported that GluN2B
antagonistspreventdisruptionofLTPbyAb.Inthecurrentstudy,however,weobservedonlypartialattenuation
of theAbeffectonLTP withRo25-6981, aGluN2B-selective antagonist.We alsotreatedhippocampal slices with
Ab in the presence of D-AP5, a broad-spectrum NMDA receptor antagonist. D-AP5 prevented the Ab-induced
loss of LTP, consistent with results on spine structural plasticity
8. Thus, our data suggest that both GluN2A and
GluN2B can contribute to Ab inhibition of LTP.
Emerging evidence indicates that the molecular pathways that classically mediate programmed cell death
(apoptosis) can also participate in non-apoptotic functions in neurons, including synaptic plasticity
9,10. In par-
ticular, caspase-3 activation has been shown to be required for hippocampal long-term depression (LTD)
11 and
for Ab inhibition of hippocampal long-term potentiation (LTP)
12. BAX, a pro-apoptotic member of the Bcl-2
protein family that is upstream of caspase-3 in the intrinsic (mitochondrial) pathway of apoptosis
13, is also
required for NMDA receptor-dependent LTD in hippocampal neurons
14. Is BAX also essential for Ab suppres-
sion of LTP? We report results in BAX knockout mice that support the conclusion that a common apoptotic
pathway is utilized for LTD and Ab suppression of LTP.
Results
Effects of Ab on synaptic transmission and plasticity inarea CA1 ofthe hippocampus. To determine whether
Ab affects basal excitatory synaptic transmission, input-output curves were recorded from area CA1 of acute
hippocampal slices preincubated with Ab (500 nM, 2 – 3 hours) and untreated control slices. A comparison of
the two curves reveals no significant difference in basal synaptic transmission following 2–3 hours of Ab
pretreatment (Figure 1A). Similarly, there was no difference in paired pulse facilitation between Ab-treated
slices and untreated slices (Figure 1B).
The effect of Ab on synaptic plasticity was also assessed in hippocampal slices. Long-term depression (LTD),
induced by 1 Hz stimulation for 15 minutes, was similar in Ab-treated and untreated slices (,20% reduction
from baseline; Figure 1C). However, when a subthreshold LTD induction protocol was used (1 Hz for 5 min
SUBJECT AREAS:
PLASTICITY
SYNAPTIC TRANSMISSION
CELLULAR NEUROSCIENCE
NEURODEGENERATION
Received
19 September 2011
Accepted
22 December 2011
Published
16 January 2012
Correspondence and
requests for materials
should be addressed to
M.S. (sheng.morgan@
gene.com) or K.M.O.
(kolsen@rockefeller.
edu)
*Current address:
Rockefeller University
1230 York Avenue
New York
SCIENTIFIC REPORTS | 2 : 225 | DOI: 10.1038/srep00225 1rather than 15 min), LTD averaged ,25% in Ab-treated slices but
was absent in untreated slices (Figure 1D), consistent with recent
reports
4,15. To measure LTP, we applied theta burst stimulation
(TBS; 10 bursts at 5 Hz; burst55 pulses, 100 Hz) after a stable 10-
minutebaselineperiod.TBS-inducedLTPaveraged12267%(n56)
of baseline in untreated hippocampal slices but was abolished in
Ab-treated slices (100 6 6%; n56; Figure 1E). Because picrotoxin
(100 mM) was present during the Ab preincubation period in these
experiments, it appears that Ab-inhibition of LTP does not reflect
excess GABAergic transmission. In sum, exposure to Ab for 2–3 hours
enhances LTD and impairs LTP, without affecting basal synaptic
transmission.
NMDA receptors are essential for Ab-inhibition of LTP. To test
theinvolvementofNMDAreceptorsinAb-mediatedsuppression of
LTP, we added the broad-spectrum NMDA receptor antagonist D-
AP5 during the Ab incubation period, and washed it out for 30 min
prior to TBS stimulation (because NMDA receptors are essential for
LTPinduction).InthepresenceofD-AP5(50 mM),Abfailedtoblock
LTP (124 6 5%; n56; Figure 2A). In the same series of experiments,
LTP was completely abolished in slices preincubated with Ab alone
(10265%;n54).Asexpected,a two-hourpreincubationwith D-AP5
alone (followed by a 30 min washout period before LTP induction)
had no effect on LTP (127 6 7%; n54; Figure 2B). Thus, NMDA
receptor activity is required during the Ab treatment period for
suppression of LTP.
The great majority of NMDA receptors in hippocampus are com-
posed of GluN1 subunits combined with either GluN2A or GluN2B
subunits. Which subtype of NMDA receptor is required for the Ab
inhibition of LTP? Ro25-6981 (3 mM), a selective GluN2B receptor
antagonist, partially attenuated Ab inhibition of LTP when present
duringtheAbincubation(12067%(n511)vs.13468%(n510)in
untreated controls; Figure 3A). LTP was not affected by a 2 h pre-
incubation with Ro25-6981 followed by a 30 min washout period
before LTP induction (135 6 7%; n54; Figure 3B). Ro25-6981 did
not reverse Ab-inhibition of LTP when applied during the LTP
induction protocol (i.e. following Ab incubation; 104 6 4%; n55;
Figure 3C), as opposed to during the Ab preincubation period. Thus
GluN2BNMDAreceptorsarenotrequiredforLTPinduction;onthe
contrary, their activity seems to contribute in part to suppression of
LTP by Ab.
AbfailstoinhibitLTPinhippocampalslicesfromBAX2/2mice.
Caspase-3 knockout mice do not show NMDA receptor dependent
Figure 1 | Ab enhances LTD and reduces LTP but has no effect on basal synaptic transmission in area CA1 of the hippocampus. (A) Input-output
curveswereplottedforuntreated(n5325)andAb-treated(n5629)hippocampalslices.Comparisonofthetwocurvesrevealsnosignificantdifference
inbasalsynaptictransmission(m52.360.1vs.2.060.1foruntreatedandAb,respectively;P50.35).Sampletracesareshownontheleft.Intheseandall
subsequent sample traces, the shock artifact has been truncated. Scale bars: 0.7 mV, 3 ms. (B) Paired pulse facilitation (20 ms interspike interval) is
unaffected by Ab treatment (n54 vs. 6 untreated slices; P51.00). Scale bars: 0.5 mV, 7 ms. (C) LTD induced by low-frequency stimulation (1 Hz) for
15 minissimilarinuntreated(n57)andAb-treated(n58)slices(P50.80).Inthisandallsubsequentfigures,sampletracesrepresentthe10 minbaseline
period and the period 30–40 min post LTD or LTP induction. (D) A subthreshold LTD induction protocol (1 Hz, 5 min) induces LTD in Ab-treated
slices (n58) but not in interleaved untreated slices (n58; * P50.03). Scale bars for C and D: 0.5 mV, 5 ms. (E) Theta-burst stimulation (TBS; arrow)
induces LTP in untreated slices (n56) but not in interleaved Ab 1 picrotoxin-treated slices (n56; * P50.04). Scale bars: 0.4 mV, 3 ms.
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hippocampal slices (n57) and slices pretreated with Ab in the presence of D-AP5 (NMDA receptor antagonist; n56), but LTP was absent in Ab-treated
slices (n54; P50.05). D-AP5 was washed out for 30 min prior to LTP induction. Sample traces are shown on the left. Scale bars: 0.4 mV, 4 ms for
untreated and Ab-treated slices; 0.6 mv, 4 ms for Ab 1 D-AP52treated slices. (B) LTP was unaffected by a 2 hr D-AP5 pretreatment followed by a
30 min washout (untreated n57, D-AP5 n54; P50.62).
Figure 3 | Inhibition of GluN2B receptors during Ab-pretreatment partially rescues Ab impairment of LTP. (A) LTP is observed following
pretreatment of hippocampal slices with Ab in the presence of Ro25-6981 (GluN2B antagonist, n511) but not in Ab-treated slices (n511). Ro25-6981
onlypartiallyrescuesLTPrelativetountreatedslices(n510;*P50.05).SampletracesbeforeandafterLTPareshownontheleft.Scalebars:0.5 mV,5 ms
for untreated and Ab 1 Ro25-69812treated slices; 0.25 mV, 5 ms for Ab-treated slices. (B) A 2 hr pretreatment with Ro25-6981 alone had no effect on
LTP (n54 and 5 for Ro25-6981 and untreated, respectively; P50.29). (C) Ro25-6981 failed to rescue LTP when it was applied after Ab (i.e. before and
during LTP induction/expression; * P50.01). n510, 11 and 5 for untreated, Ab and Ab preincubation/Ro25-6981 during LTP, respectively.
www.nature.com/scientificreports
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11,12. Knockout mice lacking BAX, a
protein upstream in the mitochondrial pathway of apoptosis, lack
LTD in hippocampus
14. Are these mice also protected from Ab
suppression of LTP? We found that CA1 LTP is similar in
hippocampal slices from BAX 2/2 and 1/1 littermates (121 6
4% vs. 130 6 4%, n512 and 9, respectively; P50.25; Figure 4). As
expected, LTP was significantly reduced following Ab pretreatment
of BAX 1/1 slices (112 6 8; n55; Figure 4A). In hippocampal
slices from BAX 2/2 littermates, however, LTP was unaffected
by Ab (122 6 5; n58; Figure 4B). Thus, BAX is required for Ab
inhibition of LTP, as it is for LTD.
Discussion
We find that Ab inhibits LTP and enhances LTD without disrupting
basal synaptic transmission. Because D-AP5 2 when coapplied with
Ab 2 largely blocks Ab inhibition of LTP, we conclude that NMDA
receptor activity is critical for Ab’s ability to suppress LTP. Attenua-
tion of Ab inhibition of LTP by the GluN2B (NR2B)-selective
antagonist Ro25-6981 has been reported in vivo
16 and in vitro in
hippocampal slices from 6-week to 4-month-old mice
5–7. In the cur-
rent study, LTP was only partially rescued when hippocampal slices
from4-to5-week-oldmicewereincubatedwithRo25-6981together
with Ab. During postnatal development, the GluN2 subunit com-
position of NMDA receptors progressively changes from GluN2B to
GluN2A
17–19.Thisdevelopmental‘switch’couldaccountforthemore
subtle Ro25-6981 effect we observe in younger slices. However, if
anything, the somewhat less mature hippocampal slices that were
used in the current study should have more GluN2B subunits and,
thus, should be more sensitive to Ro25-6981. Therefore, our results
suggest that NMDA receptors insensitive to Ro25-6981 (possibly
GluN2A-containing NMDA receptors) may also contribute to sup-
pression of LTP by Ab.
AbcandirectlyactivaterecombinantGluN2AandGluN2Brecep-
tors in heterologous expression systems
20.A b may act similarly in
neurons, though evidence for such direct action is lacking. Ab may
promote synaptic glutamate release
21,22 or impair glutamate reup-
take
23,24, which indirectly leads to aberrant NMDA receptor activa-
tion, especially of extrasynaptic GluN2B NMDA receptors
15.A b has
also been shown to cause synaptotoxic stimulation of metabotropic
glutamate receptors (mGluR5)
25, which can functionally interact
with NMDA receptors.
How might aberrant NMDA receptor activation by Ab lead to
impairment of LTP? Recent evidence has pointed to the mitochon-
drial apoptosis pathway as being critical for NMDA receptor-
dependent LTD and there are emerging mechanistic links between
LTD and Ab-mediated suppression of synaptic function
11,12,14,26,27.
We found that knockout mice lacking BAX – a Bcl2 family protein
required for mitochondrial membrane permeabilization and the
intrinsic apoptosis pathway – no longer show Ab suppression of
LTP, while LTP per se is normal. Together with recent findings
that NMDA receptor stimulation leads to significant activation of
the caspase-3 cascade
11,14, our data provide additional compelling
evidence that the mitochondrial pathway of apoptosis is centrally
involved in the synaptotoxic action of Ab.
Overactivation of NMDA receptors is often associated with
excitotoxic cell death and synaptic depression
28. However, we ob-
served that acute Ab treatment disrupts LTP in a NMDA receptor-
dependent fashion in the absence of cell death or even weakening of
basal synaptic transmission. BAX activation of caspase-3 has been
linked to non-apoptotic functions in addition to programmed cell
death
13,14. Analogous to caspase-3
11,12, BAX plays a role in LTD
induction
14 and Ab-inhibition of LTP (Figure 4). Thus, mediators
classically associated with apoptosis may play critical non-apoptotic
rolesinthepathophysiologyofAlzheimer’sdisease,andassuch,may
serve as potential therapeutic targets in this and other neurodegen-
erative diseases.
The molecular mechanisms by which activation of the apoptotic
pathway and caspase-3 lead to synaptic dysfunction remain unclear.
Intriguing data suggest that tau – a protein highly implicated in the
pathology of Alzheimer’s disease and other neurodegenerative disor-
ders
29 – is required for impaired LTP in mouse models of Alzheimer’s
disease
30 and Ab-treated hippocampal slices
31. Caspase-3 can cleave
tau at a specific site, which promotes tau aggregation
32,33. Accumu-
lation of dendritic tau may favor the interaction between PSD-95 and
NMDA receptors, thereby promoting excitotoxicity
34. Whether such
a mechanism mutually links NMDA receptors and the apoptotic
cascade, and whether this mechanism contributes to Ab impairment
of LTP, remains to be elucidated.
Figure 4 | BAXisessentialforAbinhibitionofLTP. (A)AbimpairsLTPinhippocampalslicesfromBAX1/1mice(n59and5foruntreatedandAb-
treated slices, respectively; * P50.03). (B) Ab does not impair LTP in hippocampal slices from BAX 2/2 mice (n512 and 8 untreated and Ab-treated
slices, respectively; P50.89). Sample traces from BAX 1/1 and BAX 2/2 hippocampal slices are shown above. Scale bars (A and B): 0.4 mV, 4 ms.
www.nature.com/scientificreports
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Electrophysiology. Transverse hippocampal slices (400 mm thick) were prepared
from 2- to 3-week-old mice for LTD experiments and 4- to 5-week old mice for all
other experiments. Slices were cut in artificial cerebrospinal fluid (ACSF), which
contained (in mM): 119 NaCl, 2.5 KCl, 1.3 MgSO4, 2.5 CaCl2,1N a H 2PO4,2 6
NaHCO3 and 11 glucose, equilibrated with 95% 02/5% CO2. Slices were allowed to
recover in ACSF for 45 min at 37uC followed by $1-hour incubation at room
temperature. Following the recovery period, slices were incubated with Ab(500 nM)
orAb1NMDAreceptorantagonist.Twotothreehourslater,slicesweretransferred
to a submerged recording chamber mounted on an Olympus dissecting microscope.
Untreated control slices or slices treated with NMDA receptor antagonist were
interleaved with Ab-treated slices. For experiments with BAX 2/2 mice, slices from
BAX 1/1 littermates were interleaved.
A glass pipette filled with ACSF was used to stimulate the Schaffer collaterals and
fieldexcitatory postsynaptic potentials (fEPSPs)were recorded extracellularly in area
CA1 at room temperature using low-resistance patch pipettes filled with ACSF. The
baseline stimulation rate was 0.05 Hz. fEPSPs were filtered at 2 kHz and digitized at
10 kHz with a Multiclamp (Molecular Devices, Sunnyvale, CA). Data were collected
and analyzed with pClamp 10.2.0.12 software (Molecular Devices). Fiber volley
amplitude was measured peak-to-peak. The slope of the initial rising phase (20–60%
of the peak amplitude) of the fEPSP was used as a measure of the postsynaptic
response. All data are expressed as mean 6 SEM. Student’s t-test and one-way
ANOVA were used to measure statistical significance. P#0.05 was considered
significant.
BAX null mice. BAX knockout mice were obtained from Stanley Korsemeyer
35 and
werebred/maintainedatGenentechinaccordancewiththeguidelinessetforthbyour
Institutional Animal Care and Use Committee.
Reagents. Soluble oligomeric Ab1–42 (mostly ranging from 2-mer to 6-mer
12)w a s
prepared according to the manufacturer’s instructions (Ascent Scientific, Princeton,
NJ). Briefly, Ab (1 mg/ml) was dissolved in 1, 1, 1, 3, 3, 3 – hexafluoro-2-propanol
(HFIP; Sigma, St. Louis, MO), incubated at room temperature for 1 hr with
occasional vortexing, and then sonicated for 10 min. The solution was dried under a
gentle stream of nitrogen gas, then resuspended in 100% DMSO and incubated for
12 min at room temperature. This Ab stock solution was aliquoted and stored at
–80uC. On each experimental day, an aliquot of Ab stock solution was diluted to
500 nM with D-PBS (Invitrogen, Carlsbad, CA) and incubated for 2 hr at room
temperature to permit peptide aggregation.
Thefollowingdrugs,prepareddailyfromconcentrated($10003)stocksolutions,
were also used in this study: picrotoxin (Tocris, Ellisville, MO), D-AP5 (Tocris) and
Ro25-6981 (synthesized in-house).
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